PFS tended to be lower in patients with p53-abnormal tumors compared with those with p53 wild-type tumors, with 5-year PFS rates of 65.3% versus 86.4%, although this difference did not reach statistical significance (log-rank p = 0.128) ( Figure S1A ).
← all excerpts
Prognostic Value of p53 Status in Endometrial Cancer: Real-World Evidence from a Tertiary Center.
2
0.1280
0.1280
The sentences
Patients with p53 wild-type tumors showed a trend toward longer PFS compared with those with p53-abnormal tumors; however, the difference did not reach statistical significance (log-rank test, p = 0.128).